Hepatitis C

The discovery of a new virus isn’t met with the same open arms as is the discovery of a new...Read More

The US Food and Drug Administration (FDA) has been busy, rubber-stamping several drugs that promise to improve the lives of...Read More

Drugs to treat the hepatitis C virus (HCV) are jostling for headlines as an array of new medications hits the...Read More

Update, February 9, 2016: The FDA has approved the expanded use of Daklinza ® to include patients with hepatitis C...Read More

Sound waves, such as ultrasound, are used in everything from home motion-detector sensors to evaluating fetal development during pregnancy. They’re...Read More

Update, February 9, 2016: The FDA has approved the expanded use of Daklinza ® to include patients with hepatitis C...Read More

As baby boomers age, they’ll not only face arthritis, but the possibility of another “itis” with even greater consequence—hepatitis. In...Read More

Update, October 22, 2015: The US Food and Drug Administration (FDA) issued a warning that AbbVie’s Viekira Pak ® and...Read More

The release of two new oral medications, Incivek TM and ­Victrelis TM , in May 2011 marks another significant advance...Read More

Update, October 10, 2014: On October 10, 2014, the US Food and Drug Administration (FDA) approved Harvoni™, a combination of...Read More

In May 2011, the FDA approved boceprevir (trade name Victrelis) and telaprevir (trade name Incivek), both protease inhibitors. Learn more...Read More

For years, patients with hepatitis C have complained of loss of concentration, memory lapses and shortened attention span. It turns...Read More